{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:36:39Z","timestamp":1760708199226},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,5,7]],"date-time":"2010-05-07T00:00:00Z","timestamp":1273190400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s10549-010-0911-2","type":"journal-article","created":{"date-parts":[[2010,5,6]],"date-time":"2010-05-06T04:31:02Z","timestamp":1273120262000},"page":"729-738","source":"Crossref","is-referenced-by-count":33,"title":["Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern"],"prefix":"10.1007","volume":"125","author":[{"given":"Katharina E.","family":"Effenberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elin","family":"Borgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine zu","family":"Eulenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Bartkowiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Grosser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marit","family":"Synnestvedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Kaaresen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burkhard","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jahn M.","family":"Nesland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Pantel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bjorn","family":"Naume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,7]]},"reference":[{"key":"911_CR1","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/jnci\/91.13.1113","volume":"91","author":"K Pantel","year":"1999","unstructured":"Pantel K, Cote RJ, Fodstad O (1999) Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst 91:1113\u20131124","journal-title":"J Natl Cancer Inst"},{"key":"911_CR2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJMoa0806285","volume":"360","author":"M Gnant","year":"2009","unstructured":"Gnant M, Mlineritsch B, Schippinger W et al (2009) Endocrine therapy plus zoledronic acid in premenopausal breast cancer. N Engl J Med 360:679\u2013691","journal-title":"N Engl J Med"},{"key":"911_CR3","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1200\/JCO.2008.21.2092","volume":"27","author":"HI Scher","year":"2009","unstructured":"Scher HI, Pantel K (2009) Bone marrow aspiration for disseminated tumor cell detection: a must-have test or is the jury still out? J Clin Oncol 27:1531\u20131533","journal-title":"J Clin Oncol"},{"key":"911_CR4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrc2375","volume":"8","author":"K Pantel","year":"2008","unstructured":"Pantel K, Brakenhoff RH, Brandt B (2008) Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8:329\u2013340","journal-title":"Nat Rev Cancer"},{"key":"911_CR5","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1182\/blood.V83.3.636.636","volume":"83","author":"W Brugger","year":"1994","unstructured":"Brugger W, Bross KJ, Glatt M et al (1994) Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83:636\u2013640","journal-title":"Blood"},{"key":"911_CR6","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1158\/1078-0432.CCR-07-4749","volume":"14","author":"FC Bidard","year":"2008","unstructured":"Bidard FC, Vincent-Salomon A, Gomme S et al (2008) Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse. Clin Cancer Res 14:3306\u20133311","journal-title":"Clin Cancer Res"},{"key":"911_CR7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ccr.2009.05.017","volume":"16","author":"XH Zhang","year":"2009","unstructured":"Zhang XH, Wang Q, Gerald W et al (2009) Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell 16:67\u201378","journal-title":"Cancer Cell"},{"key":"911_CR8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/0032472031000141283","volume":"1","author":"E Borgen","year":"1999","unstructured":"Borgen E, Naume B, Nesland JM et al (1999) Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy 1:377\u2013388","journal-title":"Cytotherapy"},{"key":"911_CR9","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/cncr.22076","volume":"107","author":"T Fehm","year":"2006","unstructured":"Fehm T, Braun S, Muller V et al (2006) A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation. Cancer 107:885\u2013892","journal-title":"Cancer"},{"key":"911_CR10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/scd.1.1994.3.165","volume":"3","author":"K Pantel","year":"1994","unstructured":"Pantel K, Schlimok G, Angstwurm M et al (1994) Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematother 3:165\u2013173","journal-title":"J Hematother"},{"key":"911_CR11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev.bi.63.070194.002021","volume":"63","author":"E Fuchs","year":"1994","unstructured":"Fuchs E, Weber K (1994) Intermediate filaments: structure, dynamics, function, and disease. Annu Rev Biochem 63:345\u2013382","journal-title":"Annu Rev Biochem"},{"key":"911_CR12","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/cyto.b.20114","volume":"70","author":"E Borgen","year":"2006","unstructured":"Borgen E, Pantel K, Schlimok G et al (2006) A European interlaboratory testing of three well-known procedures for immunocytochemical detection of epithelial cells in bone marrow. Results from analysis of normal bone marrow. Cytometry B Clin Cytom 70:400\u2013409","journal-title":"Cytometry B Clin Cytom"},{"key":"911_CR13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM200002243420801","volume":"342","author":"S Braun","year":"2000","unstructured":"Braun S, Pantel K, Muller P et al (2000) Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 342:525\u2013533","journal-title":"N Engl J Med"},{"key":"911_CR14","first-page":"4122","volume":"7","author":"B Naume","year":"2001","unstructured":"Naume B, Borgen E, Kvalheim G et al (2001) Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics. Clin Cancer Res 7:4122\u20134129","journal-title":"Clin Cancer Res"},{"key":"911_CR15","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1200\/JCO.2003.02.009","volume":"21","author":"G Wiedswang","year":"2003","unstructured":"Wiedswang G, Borgen E, Karesen R et al (2003) Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J Clin Oncol 21:3469\u20133478","journal-title":"J Clin Oncol"},{"key":"911_CR16","doi-asserted-by":"crossref","first-page":"8006","DOI":"10.1158\/1078-0432.CCR-05-0632","volume":"11","author":"B Willipinski-Stapelfeldt","year":"2005","unstructured":"Willipinski-Stapelfeldt B, Riethdorf S, Assmann V et al (2005) Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin Cancer Res 11:8006\u20138014","journal-title":"Clin Cancer Res"},{"key":"911_CR17","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1158\/1078-0432.CCR-03-0114","volume":"10","author":"U Woelfle","year":"2004","unstructured":"Woelfle U, Sauter G, Santjer S et al (2004) Down-regulated expression of cytokeratin 18 promotes progression of human breast cancer. Clin Cancer Res 10:2670\u20132674","journal-title":"Clin Cancer Res"},{"key":"911_CR18","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao MJ et al (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704\u2013715","journal-title":"Cell"},{"key":"911_CR19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0277-5379(87)90007-1","volume":"23","author":"M Kasper","year":"1987","unstructured":"Kasper M, Stosiek P, Typlt H et al (1987) Histological evaluation of three new monoclonal anti-cytokeratin antibodies. 1. Normal tissues. Eur J Cancer Clin Oncol 23:137\u2013147","journal-title":"Eur J Cancer Clin Oncol"},{"key":"911_CR20","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1021\/bi035072s","volume":"43","author":"A Waseem","year":"2004","unstructured":"Waseem A, Karsten U, Leigh IM et al (2004) Conformational changes in the rod domain of human keratin 8 following heterotypic association with keratin 18 and its implication for filament stability. Biochemistry 43:1283\u20131295","journal-title":"Biochemistry"},{"key":"911_CR21","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1083\/jcb.95.2.580","volume":"95","author":"J Woodcock-Mitchell","year":"1982","unstructured":"Woodcock-Mitchell J, Eichner R, Nelson WG et al (1982) Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J Cell Biol 95:580\u2013588","journal-title":"J Cell Biol"},{"key":"911_CR22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1749-6632.1985.tb50419.x","volume":"455","author":"TT Sun","year":"1985","unstructured":"Sun TT, Tseng SC, Huang AJ et al (1985) Monoclonal antibody studies of mammalian epithelial keratins: a review. Ann N Y Acad Sci 455:307\u2013329","journal-title":"Ann N Y Acad Sci"},{"key":"911_CR23","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1021\/pr8009758","volume":"8","author":"K Bartkowiak","year":"2009","unstructured":"Bartkowiak K, Wieczorek M, Buck F et al (2009) Two-dimensional differential gel electrophoresis of a cell line derived from a breast cancer micrometastasis revealed a stem\/progenitor cell protein profile. J Proteome Res 8:2004\u20132014","journal-title":"J Proteome Res"},{"key":"911_CR24","doi-asserted-by":"crossref","first-page":"9067","DOI":"10.1200\/JCO.2004.01.0454","volume":"23","author":"LM McShane","year":"2005","unstructured":"McShane LM, Altman DG, Sauerbrei W et al (2005) Reporting recommendations for tumor marker prognostic studies. J Clin Oncol 23:9067\u20139072","journal-title":"J Clin Oncol"},{"key":"911_CR25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/path.1559","volume":"203","author":"DM Abd El-Rehim","year":"2004","unstructured":"Abd El-Rehim DM, Pinder SE, Paish CE et al (2004) Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol 203:661\u2013671","journal-title":"J Pathol"},{"key":"911_CR26","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0002-9440(10)64476-8","volume":"161","author":"M Rijn van de","year":"2002","unstructured":"van de Rijn M, Perou CM, Tibshirani R et al (2002) Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol 161:1991\u20131996","journal-title":"Am J Pathol"},{"key":"911_CR27","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1158\/1078-0432.CCR-03-0373","volume":"10","author":"B Naume","year":"2004","unstructured":"Naume B, Wiedswang G, Borgen E et al (2004) The prognostic value of isolated tumor cells in bone marrow in breast cancer patients: evaluation of morphological categories and the number of clinically significant cells. Clin Cancer Res 10:3091\u20133097","journal-title":"Clin Cancer Res"},{"key":"911_CR28","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMoa050434","volume":"353","author":"S Braun","year":"2005","unstructured":"Braun S, Vogl FD, Naume B et al (2005) A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 353:793\u2013802","journal-title":"N Engl J Med"},{"key":"911_CR29","doi-asserted-by":"crossref","first-page":"R1174","DOI":"10.1186\/bcr1360","volume":"7","author":"C Schindlbeck","year":"2005","unstructured":"Schindlbeck C, Kampik T, Janni W et al (2005) Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas. Breast Cancer Res 7:R1174\u2013R1185","journal-title":"Breast Cancer Res"},{"key":"911_CR30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ijc.20655","volume":"114","author":"MJ Slade","year":"2005","unstructured":"Slade MJ, Singh A, Smith BM et al (2005) Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4\u00a0years. Int J Cancer 114:94\u2013100","journal-title":"Int J Cancer"},{"key":"911_CR31","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1056\/NEJMoa021967","volume":"347","author":"MJ Vijver van de","year":"2002","unstructured":"van de Vijver MJ, He YD, van\u2019t Veer LJ et al (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999\u20132009","journal-title":"N Engl J Med"},{"key":"911_CR32","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1097\/01.LAB.0000038508.86221.B3","volume":"82","author":"E Korsching","year":"2002","unstructured":"Korsching E, Packeisen J, Agelopoulos K et al (2002) Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis. Lab Invest 82:1525\u20131533","journal-title":"Lab Invest"},{"key":"911_CR33","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/sj.bjc.6601658","volume":"90","author":"E Korsching","year":"2004","unstructured":"Korsching E, Packeisen J, Helms MW et al (2004) Deciphering a subgroup of breast carcinomas with putative progression of grade during carcinogenesis revealed by comparative genomic hybridisation (CGH) and immunohistochemistry. Br J Cancer 90:1422\u20131428","journal-title":"Br J Cancer"},{"key":"911_CR34","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.molonc.2007.03.004","volume":"1","author":"B Naume","year":"2007","unstructured":"Naume B, Zhao X, Synnestvedt M et al (2007) Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer. Mol Oncol 1:160\u2013171","journal-title":"Mol Oncol"},{"key":"911_CR35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc2620","volume":"9","author":"K Polyak","year":"2009","unstructured":"Polyak K, Weinberg RA (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9:265\u2013273","journal-title":"Nat Rev Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-0911-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-010-0911-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-0911-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T09:43:26Z","timestamp":1591263806000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-010-0911-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,7]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["911"],"URL":"https:\/\/doi.org\/10.1007\/s10549-010-0911-2","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,7]]}}}